Jonas Olesen

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

Gregory Y.H. Lip, Jesper Lindhardsen, Deirdre A. Lane et al. · Thrombosis and Haemostasis · 2011 · 428 citations

Medicine, Cardiology, Pharmacotherapy +17

Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

Anne‐Marie Schjerning Olsen, Emil Loldrup Fosbøl, Jesper Lindhardsen et al. · Circulation · 2011 · 330 citations

Medicine, Pharmacology, Pharmacotherapy +16

Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction

Anne‐Marie Schjerning Olsen, Emil Loldrup Fosbøl, Jesper Lindhardsen et al. · Circulation · 2012 · 115 citations · Full text

Medicine, Cardiology, Pharmacology +11

Increased Mortality Associated With Low Use of Clopidogrel in Patients With Heart Failure and Acute Myocardial Infarction Not Undergoing Percutaneous Coronary Intervention

Lisbeth Bonde, Rikke Sørensen, Emil Loldrup Fosbøl et al. · Journal of the American College of Cardiology · 2010 · 21 citations

Medicine, Cardiology, Pharmacotherapy +17